Immunohistochemical analysis (IHC) revealed that those tumor cells tested positive for CK7, CK20 (weakly), MUC5AC, CEA, and CA19-9 and negative for MUC2, MUC6, and CDX2. This evidence concerns the gene CDX2 and neoplasm.